Cambridge Investment Research Advisors’s BlackRock ETF Trust II iShares AAA CLO Active ETF CLOA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
41,159
+8,503
+26% +$441K ﹤0.01% 1640
2026
Q1
$1.69M Buy
32,656
+828
+3% +$42.9K ﹤0.01% 1731
2025
Q4
$1.65M Buy
31,828
+8,264
+35% +$428K ﹤0.01% 1702
2025
Q3
$1.23M Buy
23,564
+5,425
+30% +$281K ﹤0.01% 1896
2025
Q2
$942K Buy
18,139
+4,310
+31% +$223K ﹤0.01% 1997
2025
Q1
$716K Buy
13,829
+6,954
+101% +$360K ﹤0.01% 2143
2024
Q4
$356K Buy
6,875
+283
+4% +$14.7K ﹤0.01% 2699
2024
Q3
$343K Buy
6,592
+2,672
+68% +$139K ﹤0.01% 2730
2024
Q2
$204K Buy
+3,920
New +$203K ﹤0.01% 3013

Other funds holding CLOA

Cambridge Investment Research Advisors's CLOA Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its BlackRock ETF Trust II iShares AAA CLO Active ETF (CLOA) stake by 26% in Q2 2026, buying an estimated $441K and bringing the position to 41,159 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Cambridge Investment Research Advisors first reported a position in CLOA in Q2 2024 and has held it in 9 quarters since. 249 funds tracked by Wall St. Rank hold CLOA as of Q2 2026.

  • Cambridge Investment Research Advisors held 41,159 shares of BlackRock ETF Trust II iShares AAA CLO Active ETF worth $2.14M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 8,503 BlackRock ETF Trust II iShares AAA CLO Active ETF shares in Q2 2026, an estimated $441K.
  • BlackRock ETF Trust II iShares AAA CLO Active ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1640 holding.
  • Cambridge Investment Research Advisors first reported a position in BlackRock ETF Trust II iShares AAA CLO Active ETF in Q2 2024 and has held it in 9 quarters since.
  • 249 funds tracked by Wall St. Rank held BlackRock ETF Trust II iShares AAA CLO Active ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.